Oxidative pathways as a drug target for the treatment of autism

Author： Villagonzalo Kristi-Ann Dodd Seetal Dean Olivia Gray Kylie Tonge Bruce Berk Michael

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.12, 2010-12, pp. : 1301-1310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer

By Montero Alberto J.

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1385-1396

Adis International

Access to resources Recommend Favorite

Apoptotic Signaling Pathways as a Target for the Treatment of Liver Diseases

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 14, 2008-12 ,pp. : 1485-1493

Bentham Science Publishers

Access to resources Recommend Favorite

Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 253-256

Bentham Science Publishers

Access to resources Recommend Favorite

Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders

Current Pharmaceutical Design, Vol. 19, Iss. 36, 2013-11 ,pp. : 6480-6490

Bentham Science Publishers

Access to resources Recommend Favorite

The Wnt-dependent signaling pathways as target in oncology drug discovery

By Janssens Nico Janicot Michel Perera Tim

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 263-280

Springer Publishing Company

Access to resources Recommend Favorite